HDL Therapeutics


HDL Therapeutics is a commercial-stage biotechnology company with an FDA-approved therapy for reducing coronary atheroma in a rare cardiovascular disease.

Industries

Employees

1-10

Links


Org chart

Michael A. Matin
Chairman & CEO
Collapse
H. Bryan Brewer
Chief Scientific Officer
Michael McCann
Chief Commercial Officer
Timothy J. Perlman
Chief Technology Officer


Offices